Sampo plc’s share buybacks 02/12/2021
SAMPO PLC STOCK EXCHANGE RELEASE 03/12/2021 at 08:30 am
Sampo plc’s share buybacks 02/12/2021
On 02/12/2021 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:
|Sampo plc’s share buybacks||Aggregated daily volume (in number of shares)||Daily weighted average price of the purchased shares*||Market (MIC Code)|
*rounded to two decimals
On 1 October 2021, Sampo announced a share buyback programme of up to a maximum of EUR 750 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 4 October 2021, is based on the authorization granted by Sampo's Annual General Meeting on 19 May 2021.
After the disclosed transactions, the company owns in total 6,135,528 Sampo A shares representing 1.10 per cent of the total number of shares in Sampo plc.
Details of each transaction are included as an appendix of this announcement.
On behalf of Sampo plc,
Exane BNP Paribas
For further information, please contact:
Head of Investor Relations
tel. +358 10 516 0030
London Stock Exchange
The principal media
Financial Supervisory Authority
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Alation Welcomes Tim Harford OBE as Keynote Speaker at revAlation in London18.8.2022 09:00:00 CEST | Press release
World renowned behavioural economist joins The Very Group CDO to keynote Alation’s industry conference LONDON, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Alation Inc., the leader inenterprise data intelligence solutions, today announced that revAlation, its flagship industry conference for data professionals across EMEA, will take place on 4th October and 5th October at County Hall, London. The two-day event will feature data networking opportunities, data training, and keynotes from award winning economist, journalist, and broadcaster Tim Harford, and Chief Data Officer of The Very Group, Steve Pimblett. Tim Harford is a bestselling author of books about economics and data, and the writer of the award-winning Financial Times column, The Undercover Economist. Harford will keynote the event and discuss how to use data and economics in everyday life. Steve Pimblett is the Chief Data Officer at leading UK and Ireland online retailer, The Very Group. Pimblett is an experienced data professional, ha
Sampo plc: Disclosure Under Chapter 9 Section 5 of the Securities Market Act (BlackRock, Inc.)18.8.2022 08:30:00 CEST | Press release
SAMPO PLC STOCK EXCHANGE RELEASE 18 August 2022 at 9:30 am Sampo plc: Disclosure Under Chapter 9 Section 5 of the Securities Market Act (BlackRock, Inc.) Sampo plc (business code 0142213-3) has received a disclosure under Chapter 9, Section 5 of the Securities Markets Act, according to which the voting rights attached to Sampo A shares (ISIN: FI009003305) owned directly or indirectly by BlackRock, Inc. (USA tax ID 32-0174421) and its funds decreased on 16 August 2022 below five (5) per cent of Sampo plc’s total voting rights. Sampo's share capital comprises 533,261,351 shares, of which 533,061,351 are A shares and 200,000 are B shares. Each A share entitles its holder to one (1) vote and each B share to five (5) votes. Thus, the total number of votes is 534,061,351. Total positions of BlackRock, Inc and its funds subject to the notification: % of shares and voting rights (total of A)% of shares and voting rights through financial instruments (total of B)Total of both in % (A+B)Resultin
Systemair's Interim Report for the first quarter will be presented on August 2518.8.2022 08:00:00 CEST | Press release
Press Release, 18 August 2022 Systemair ABs (NASDAQ OMX Stockholm: SYSR) Interim Report Q1 for the financial year 2022/23 will be published at 13:00 CET on August 25, 2022. A telephone conference will be held at 13:30 CET on August 25, 2022. The report will be presented by Roland Kasper, CEO, and Anders Ulff, CFO. In order to participate in the telephone conference: Call 010-884 8016 alternative international call +44 20 3936 2999 and enter code 539199 minutes before start. The presentation will be published on group.systemair.com For further information contact: Roland Kasper, CEO, + 46 73 094 40 13 Anders Ulff, CFO, + 46 70 577 40 09 Systemair AB, SE-739 30 Skinnskatteberg, Sweden, +46 222 440 00, www.systemair.com Systemair in brief Systemair is a leading ventilation company with operations in 52 countries in Europe, North America, the Middle East, Asia, Australia and Africa. The Company had sales of SEK 9.6 billion in the 2021/22 financial year and today employs approximately 6,700
Ultimovacs Expands High Dose Cohort Size in TENDU Phase I Prostate Cancer Trial after Safety Review18.8.2022 08:00:00 CEST | Press release
The TENDU interim safety results from nine patients show no safety concernsTrial extended to enroll up to three additional patients at the highest dose levelTENDU designed to evaluate the Tetanus-Epitope Targeting (TET)-platform in patients with prostate cancer Oslo, 18August 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, has completed treatment of three patients at the highest dose cohort in the phase I TENDU trial without any safety concerns. Based on these results, the company plans to enroll up to three additional patients at the highest dose level. The Drug Safety Monitoring Board, a group of experts set up to monitor patient safety during a clinical trial, found no safety concerns in any of the three dose cohorts. A total of nine patients have now been treated; three at each dose level (40 mcg, 400 mcg and 960 mcg). Ultimovacs plans to enroll up to three additional patients at the highest dose level (960 mcg) pro
Systemairs rapport för det första kvartalet presenteras den 25 augusti18.8.2022 08:00:00 CEST | Pressemelding
Pressmeddelande 18 augusti 2022 Systemair ABs (NASDAQ OMX Stockholm: SYSR) delårsrapport Q1 för räkenskapsåret 2022/23 kommer att offentliggöras kl. 13:00 CET den 25 augusti 2022. En telefonkonferens arrangeras kl. 13:30 CET den 25 augusti 2022. Rapporten presenteras av Roland Kasper, CEO, samt Anders Ulff, CFO. För att delta i telefonkonferensen: Ring 010-884 8016 alt. internationellt +44 20 3936 2999 och uppge kod 539199 minuter före start. Presentationen publiceras på group.systemair.com För ytterligare information kontakta: Roland Kasper, CEO, + 46 73 094 40 13 Anders Ulff, CFO, + 46 70 577 40 09 Systemair AB, 739 30 Skinnskatteberg, 0222-440 00, www.systemair.com Systemair i korthet Systemair är ett ledande ventilationsföretag med verksamhet i 52 länder i Europa, Nordamerika, Mellanöstern, Asien, Australien och Afrika. Bolaget omsatte 9,6 miljarder kronor räkenskapsåret 2021/22 och har idag cirka 6 700 anställda. Sedan grundandet av Systemair 1974 har bolaget uppvisat positiva rör